Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Stroke

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000025518.34157.51PMID 12154275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathological endpoints in experimental stroke pharmacotherapy: The importance of both early and late evaluation

  2005cited by this paper
• Historical keywords: trial.

  2004cited by this paper
• Reemergence of Stroke Deficits With Midazolam Challenge

  2002cited by this paper
• Modified National Institutes of Health Stroke Scale for Use in Stroke Clinical Trials: Prospective Reliability and Validity

  2002cited by this paper
• Clomethiazole Acute Stroke Study in Ischemic Stroke (CLASS-I): Final Results

  2002cited by this paper
• Psychological Evaluation of Young Women after Medical Treatment for Central Precocious Puberty

  2002cited by this paper
• Neuroprotection is unlikely to be effective in humans using current trial designs: an opposing view.

  2002cited by this paper
• Inhibition of Cyclin-Dependent Kinases Improves CA1 Neuronal Survival and Behavioral Performance after Global Ischemia in the Rat

  2002cited by this paper
• Neuroprotection is unlikely to be effective in humans using current trial designs.

  2002cited by this paper
• Cell proliferation and differentiation from ependymal, subependymal and choroid plexus cells in response to stroke in rats.

  2002cited by this paper
• Modulation of use-dependent plasticity by d-amphetamine.

  2002cited by this paper
• The Fugl-Meyer Assessment of Motor Recovery after Stroke: A Critical Review of Its Measurement Properties

  2002cited by this paper
• Modulation of use‐dependent plasticity by d‐amphetamine

  2002cited by this paper
• Effects of Thyroid Hormone on mRNAs of Phosphoglycerate Mutase Subunits in Rat Muscle during Development

  2002cited by this paper
• Fiblast (Trafermin) in Acute Stroke: Results of the European-Australian Phase II/III Safety and Efficacy Trial

  2002cited by this paper
• Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.

  2001cited by this paper
• CSF filtration is an effective treatment of Guillain–Barré syndrome

  2001cited by this paper
• Neuroprotection for Ischaemic Stroke

  2001cited by this paper
• A Double-Blind, Placebo-Controlled Study of the Use of Amphetamine in the Treatment of Aphasia

  2001cited by this paper
• MEGA TRIALS VERSUS SMALL TRIALS IN STROKE

  2001cited by this paper
• Ensuring patient safety in clinical trials for treatment of acute stroke.

  2001cited by this paper
• Stroke Recovery Profile and the Modified Rankin Assessment

  2001cited by this paper
• Recommendations for Clinical Trial Evaluation of Acute Stroke Therapies

  2001cited by this paper
• Acute Ischemic Stroke Treatment: State of the Art and New Options

  2001cited by this paper
• Potentially Reversible Factors during the Very Acute Phase of Stroke and Their Impact on the Prognosis: Is There a Large Therapeutic Potential to Be Explored?

  2001cited by this paper
• Trends in Acute Ischemic Stroke Trials Through the 20th Century

  2001cited by this paper
• Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits After Stroke in Rats

  2001cited by this paper
• Why are stroke patients excluded from TPA therapy?

  2001cited by this paper
• Treatment of stroke in rat with intracarotid administration of marrow stromal cells

  2001cited by this paper
• Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia

  2001cited by this paper
• Early stroke: a dynamic process.

  2001cited by this paper
• Systematic Review of Prognostic Models in Patients with Acute Stroke

  2001cited by this paper
• A Double-Blind Placebo-Controlled Study of the Effects of Amphetamine and Physiotherapy after Stroke

  2001cited by this paper
• Advances in Neuroprotection Trials

  2001cited by this paper
• What have we learned from clinical neuroprotective trials?

  2001cited by this paper
• Perfusion Mapping Using Computed Tomography Allows Accurate Prediction of Cerebral Infarction in Experimental Brain Ischemia

  2001cited by this paper
• Bilateral movement enhances ipsilesional cortical activity in acute stroke: A pilot functional MRI study

  2001cited by this paper
• Stroke Therapy Academic Industry Roundtable. Recommendations for Clinical Trial Evaluation of Acute Stroke Therapies (Stroke Therapy Academic Industry Roundtable II (STAIR_II)).

  2001cited by this paper
• Cerebral Ischemia: From Animal Studies to Clinical Practice. Should the Methods Be Reviewed?

  2001cited by this paper
• Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials

  2001cited by this paper
• The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator–treated stroke (CLASS-T)

  2001cited by this paper
• Perfusion Thresholds in Human Cerebral Ischemia: Historical Perspective and Therapeutic Implications

  2001cited by this paper
• A Modified National Institutes of Health Stroke Scale for Use in Stroke Clinical Trials: Preliminary Reliability and Validity

  2001cited by this paper
• Transplantation of cultured human neuronal cells for patients with stroke.

  2001cited by this paper
• Use of anti-ICAM-1 therapy in ischemic stroke

  2001cited by this paper
• New imaging strategies for patient selection for thrombolytic and neuroprotective therapies

  2001cited by this paper
• Growth Factors and Cerebral Ischemia

  2001cited by this paper
• Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats

  2001cited by this paper
• Nimodipine in Animal Model Experiments of Focal Cerebral Ischemia: A Systematic Review

  2001cited by this paper
• A three-item scale for the early prediction of stroke recovery.

  2001cited by this paper
• Combination Therapy Stroke Trial: Recombinant Tissue-Type Plasminogen Activator with/without Lubeluzole

  2001cited by this paper
• Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study.

  2001cited by this paper
• Stroke Therapy Academic Industry Roundtable. Recommendations for clinical trial evaluation of acute stroke therapies.

  2001cited by this paper
• Neuroprotection and traumatic brain injury: the search continues.

  2001cited by this paper
• Non‐Pharmacologic (Physiologic) Neuroprotection in the Treatment of Brain Ischemia

  2001cited by this paper
• The role of hyperglycemia in acute stroke.

  2001cited by this paper
• EGASIS - Early GABA-ergic Activation Study In Stroke. A multicentre, randomised, placebo-controlled, double blind trial to evaluate the use of diazepam in the acute phase of stroke

  2001cited by this paper
• A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke.

  2001cited by this paper
• Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia.

  2001cited by this paper
• Mapping the ischaemic penumbra with PET: a new approach.

  2001cited by this paper
• Glycine Antagonist (GV150526) in Acute Stroke: A Multicentre, Double-Blind Placebo-Controlled Phase II Trial

  2001cited by this paper
• The Failure of Neuronal Protective Agents Versus the Success of Thrombolysis in the Treatment of Ischemic Stroke

  2001cited by this paper
• Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview

  2001cited by this paper
• Acute Ischemic Stroke Treatment: State of the Art and New Options

  2001cited by this paper
• Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.

  2001cited by this paper
• Dendritic Spines Lost during Glutamate Receptor Activation Reemerge at Original Sites of Synaptic Contact

  2001cited by this paper
• Burden of disease--implications for future research.

  2001cited by this paper
• Role of adaptive plasticity in recovery of function after damage to motor cortex

  2001cited by this paper
• Body weight-supported treadmill training after stroke

  2001cited by this paper
• The norepinephrine precursor L-threo-3,4-dihydroxyphenylserine facilitates motor recovery in chronic stroke patients.

  2001cited by this paper
• Entry Criteria and Baseline Characteristics Predict Outcome in Acute Stroke Trials

  2001cited by this paper
• Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke.

  2001cited by this paper
• Apoptosis After Experimental Stroke: Fact or Fashion?

  2000cited by this paper
• Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice.

  2000cited by this paper
• Defining post-stroke recovery: implications for design and interpretation of drug trials.

  2000cited by this paper
• RESTORATIVE NEUROLOGY. ADVANCES IN PHARMACOTHERAPY FOR RECOVERY AFTER STROKE.

  2000cited by this paper
• Brain plasticity and stroke rehabilitation. The Willis lecture.

  2000cited by this paper
• Ischemic Penumbra: Evidence From Functional Imaging in Man

  2000cited by this paper
• The future of stroke treatment.

  2000cited by this paper
• Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.

  2000cited by this paper
• Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

  2000cited by this paper
• Growth Hormone-Releasing Hormone: Past and Present

  2000cited by this paper
• Long-term functional end points following middle cerebral artery occlusion in the rat.

  2000cited by this paper
• Neuroprotection disappointment yet aGAIN.

  2000cited by this paper
• Functional assessments in mice and rats after focal stroke.

  2000cited by this paper
• Finding the Most Powerful Measures of the Effectiveness of Tissue Plasminogen Activator in the NINDS tPA Stroke Trial

  2000cited by this paper
• NMDA Receptor Blockade Fails to Alter Axonal Injury in Focal Cerebral Ischemia

  2000cited by this paper
• Animal models.

  2000cited by this paper
• Cyclin-dependent kinases as a therapeutic target for stroke.

  2000cited by this paper
• Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

  2000cited by this paper
• Use of pharmacotherapy in the treatment of aphasia.

  2000cited by this paper
• The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats.

  2000cited by this paper
• Recovery recapitulates ontogeny.

  2000cited by this paper
• Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after stroke.

  2000cited by this paper
• Neuroprotection failure in stroke.

  2000cited by this paper
• Apoptosis and Cerebral Ischemia

  2000cited by this paper
• Seizure Control as an Indicator of Therapeutic Usefulness

  2000cited by this paper
• Why do neuroprotective drugs work in animals but not humans?

  2000cited by this paper
• Treatment of acute ischemic stroke.

  2000cited by this paper
• Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.

  2000cited by this paper

• GW201 mediates neuroprotection via allosteric modulation of NMDA receptor activity in the middle cerebral artery occlusion (MCAO) model.

  2026cites this paper
• Efficacy and safety of idebenone tablets in patients with post-stroke cognitive impairment: a real-world study

  2025cites this paper
• Intraperitoneal administration of NMDA-Subunit NR1-receptor antibodies does not improve long-term outcome in a murine MCAo-stroke model

  2025cites this paper
• Future Perspectives of NMDAR in CNS Disorders

  2025cites this paper
• Adaptogens in Long-Lasting Brain Fatigue: An Insight from Systems Biology and Network Pharmacology

  2025cites this paper
• Buyang Huanwu decoction promotes gray and white matter remyelination by inhibiting Notch signaling activation in the astrocyte and microglia after ischemic stroke.

  2025cites this paper
• Targeting Ischemic Stroke with Neural Stem Cells: Insights into Endogenous Repair Mechanisms, Biomaterial-Based Delivery, and Exosome Therapies

  2025cites this paper
• Using human genomics to validate drug targets for acute ischemic stroke.

  2025cites this paper
• Exploring NMDAR pathways in ischemic stroke: implications for neurotoxic and neuroprotective mechanisms and therapeutic strategies

  2025cites this paper
• A large animal model for focal stroke: Photothrombotic lesion in the cortex of Danish Landrace pigs.

  2025cites this paper
• Motor impairment and adaptation in a novel non-human primate model of internal capsule infarct

  2025cites this paper
• Forebrain neural progenitors effectively integrate into host brain circuits and improve neural function after ischemic stroke

  2025cites this paper
• Clinical Development of the GluN2B-selective NMDA Receptor Inhibitor NP10679 for the Treatment of Neurologic Deficit after Subarachnoid Hemorrhage.

  2024cites this paper
• Role of Cholesterol Metabolic Enzyme CYP46A1 and Its Metabolite 24S-Hydroxycholesterol in Ischemic Stroke

  2024cites this paper
• Psychotomimetic compensation versus sensitization

  2024cites this paper
• Signaling roles of sphingolipids in the ischemic brain and their potential utility as therapeutic targets.

  2024cites this paper
• Fluorescence and magnetic resonance imaging of ONL-93 cells in a rat model of ischemic.

  2024cites this paper
• Abolishing UCHL1’s hydrolase activity exacerbates ischemia-induced axonal injury and functional deficits in mice

  2024cites this paper
• Sphenopalatine ganglion stimulation for the treatment of cerebrovascular ischemia

  2024cites this paper
• Activation of adult endogenous neurogenesis by a hyaluronic acid collagen gel containing basic fibroblast growth factor promotes remodeling and functional recovery of the injured cerebral cortex

  2024cites this paper
• Establishment of a novel protocol for assessing the severity of subarachnoid hemorrhage in circle Willis perforation mouse model

  2024cites this paper
• Artificial Intelligence as a Replacement for Animal Experiments in Neurology: Potential, Progress, and Challenges

  2024cites this paper
• Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke

  2024cites this paper
• Emerging Roles of Exosomes in Stroke Therapy

  2024cites this paper
• Xenon and Argon as Neuroprotective Treatments for Perinatal Hypoxic-Ischemic Brain Injury: A Preclinical Systematic Review and Meta-Analysis

  2024cites this paper
• Inhibiting NLRP3 inflammasome signaling pathway promotes neurological recovery following hypoxic-ischemic brain damage by increasing p97-mediated surface GluA1-containing AMPA receptors

  2023cites this paper
• Tetramethylpyrazine promotes axonal remodeling and modulates microglial polarization via JAK2-STAT1/3 and GSK3-NFκB pathways in ischemic stroke.

  2023cites this paper
• Ketogenic diet and calorie-restricted diet attenuate ischemic brain injury via UBR4 and downstream CamkⅡ/TAK1/JNK signaling

  2023cites this paper
• Three-dimensional simulations of embolic stroke and an equation for sizing emboli from imaging

  2023cites this paper
• Animal models and human tissue compared to better understand and treat the epilepsies

  2023cites this paper
• Use of animal models has not contributed to development of Use of animal models has not contributed to development of acute stroke therapies: con acute stroke therapies: con you.

  2022cites this paper
• A Novel Hybrid of Telmisartan and Borneol Ameliorates Neuroinflammation and White Matter Injury in Ischemic Stroke Through ATF3/CH25H Axis.

  2022cites this paper
• Efficacy and safety of LongShengZhi capsule on functional recovery after acute ischemic stroke (LONGAN): Protocol and statistical analysis plan for a randomized, double-blind, placebo-controlled trial

  2022cites this paper
• An injectable and photocurable methacrylate-silk fibroin hydrogel loaded with bFGF for spinal cord regeneration

  2022cites this paper
• Predictors for Returning to Paid Work after Transient Ischemic Attack and Minor Ischemic Stroke

  2022cites this paper
• Mechanistic Insight on Autophagy Modulated Molecular Pathways in Cerebral Ischemic Injury: From Preclinical to Clinical Perspective

  2022cites this paper
• Proteasome and Neuroprotective Effect of Hyperbaric Oxygen Preconditioning in Experimental Global Cerebral Ischemia in Rats

  2022cites this paper
• Promising Cerebral Blood Flow Enhancers in Acute Ischemic Stroke

  2022cites this paper
• K+-Dependent Na+/Ca2+ Exchanger Isoform 2, Nckx2, Takes Part in the Neuroprotection Elicited by Ischemic Preconditioning in Brain Ischemia

  2022cites this paper
• The Impact of Ischemic Stroke on Gray and White Matter Injury Correlated With Motor and Cognitive Impairments in Permanent MCAO Rats: A Multimodal MRI-Based Study

  2022cites this paper
• Anesthesia for acute stroke

  2022cites this paper
• Spontaneous behavioural recovery following stroke relates to the integrity of sensory and association cortices

  2022cites this paper
• Physical exercise promotes integration of grafted cells and functional recovery in an acute stroke rat model

  2022cites this paper
• Spontaneous Behavioural Recovery Following Stroke Relates to the Integrity of Parietal and Temporal Regions

  2022cites this paper
• Insight Into the Mechanism of Exercise Preconditioning in Ischemic Stroke

  2022cites this paper
• The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca2+ Permeability of GluN1/GluN2A N-Methyl-d-Aspartate Receptors

  2021cites this paper
• Brain Health—Curbing Stroke, Heart Disease, and Dementia

  2021cites this paper
• Three dimensional simulations of embolic stroke: clinical comparisons and an equation for sizing emboli from imaging

  2021cites this paper
• Neues beim Schlaganfall – Teil 2: Prävention

  2021cites this paper
• Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research

  2021cites this paper
• On the Sensitivity Analysis of Porous Finite Element Models for Cerebral Perfusion Estimation

  2021cites this paper
• The Negative Allosteric Modulator EU1794-4 Reduces Single Channel Conductance and Ca2+ Permeability of GluN1/GluN2A NMDA Receptors

  2021cites this paper
• Aagab acts as a novel regulator of NEDD4-1-mediated Pten nuclear translocation to promote neurological recovery following hypoxic-ischemic brain damage

  2021cites this paper
• A GluN2B-selective inhibitor of NMDA receptor function with enhanced potency at acidic pH and oral bioavailability for clinical use

  2021cites this paper
• Cerebrovascular Infarct: Stroke

  2021cites this paper
• Oleanolic Acid Provides Neuroprotection against Ischemic Stroke through the Inhibition of Microglial Activation and NLRP3 Inflammasome Activation

  2021cites this paper
• Large-Scale Multivariate Analysis to Interrogate an Animal Model of Stroke: Novel Insights Into Poststroke Pathology

  2021cites this paper
• Functional Assessment of Stroke-Induced Regulation of miR-20a-3p and Its Role as a Neuroprotectant

  2021cites this paper
• Brain vulnerability and viability after ischaemia

  2021cites this paper
• Preclinical Stroke Research and Translational Failure: A Bird’s Eye View on Preventable Variables

  2021cites this paper
• Neues beim Schlaganfall: Prävention

  2021cites this paper
• A Glutamate N-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B–Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical Use

  2021cites this paper
• Translational Neurocritical Care Research: Advancing Understanding and Developing Therapeutics

  2020cites this paper
• The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation

  2020cites this paper
• Translational Intracerebral Hemorrhage Research: Has Current Neuroprotection Research ARRIVEd at a Standard for Experimental Design and Reporting?

  2020cites this paper
• Shuxuening injection facilitates neurofunctional recovery via down-regulation of G-CSF-mediated granulocyte adhesion and diapedesis pathway in a subacute stroke mouse model.

  2020cites this paper
• Translational Genomics in Neurocritical Care: a Review

  2020cites this paper
• The cell-permeable mitochondrial calcium uniporter inhibitor Ru265 preserves cortical neuron respiration after lethal oxygen glucose deprivation and reduces hypoxic/ischemic brain injury

  2020cites this paper
• MicroRNAs as regulators of brain function and targets for treatment of epilepsy

  2020cites this paper
• Remote ischemic conditioning for acute moderate ischemic stroke (RICAMIS): Rationale and design

  2020cites this paper
• A porous circulation model of the human brain for in silico clinical trials in ischaemic stroke

  2020cites this paper
• Rg1 in combination with mannitol protects neurons against glutamate-induced ER stress via the PERK-eIF2 α-ATF4 signaling pathway.

  2020cites this paper
• Inhibition of LPA5 Activity Provides Long-Term Neuroprotection in Mice with Brain Ischemic Stroke

  2020cites this paper
• Natural compounds modulate the autophagy with potential implication of stroke

  2020cites this paper
• Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers

  2020cites this paper
• Acute‐stage MRI cerebral oxygen consumption biomarkers predict 24‐hour neurological outcome in a rat cardiac arrest model

  2020cites this paper
• Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke

  2020cites this paper
• Relevance of Porcine Stroke Models to Bridge the Gap from Pre-Clinical Findings to Clinical Implementation

  2020cites this paper
• Enhanced white matter reorganization and activated brain glucose metabolism by enriched environment following ischemic stroke: Micro PET/CT and MRI study.

  2020cites this paper
• Blowing up Neural Repair for Stroke Recovery

  2020cites this paper
• Non-invasive treatment with near-infrared light: A novel mechanisms-based strategy that evokes sustained reduction in brain injury after stroke

  2020cites this paper
• Molecular changes in glaucomatous trabecular meshwork. Correlations with retinal ganglion cell death and novel strategies for neuroprotection.

  2020cites this paper
• Issues important to the design of stroke recovery trials.

  2020cites this paper
• Filling the gaps on stroke research: Focus on inflammation and immunity

  2020cites this paper
• Newer pharmacological approaches for antioxidant neuroprotection in traumatic brain injury

  2019cites this paper
• La myéloperoxydase : biomarqueur diagnostique de l'accident vasculaire cérébral ischémique ?

  2019cites this paper
• Dementia: Paradigm shifting into high gear

  2019cites this paper
• Development of a Novel Canine Model of Ischemic Stroke: Skull Base Approach with Transient Middle Cerebral Artery Occlusion.

  2019cites this paper
• Chemical constituents from the stems of Machilus philippinensis Merr. and the neuroprotective activity of cinnamophilin

  2019cites this paper
• Therapeutic hypothermia: Applications in adults with acute ischemic stroke

  2019cites this paper
• Inhaled xenon neuro- and cardioprotection following out-of-hospital cardiac arrest. A randomized, controlled trial

  2019cites this paper
• Overview of systematic reviews with meta-analyses on Chinese herbal medicine in stroke management

  2019cites this paper
• Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage

  2019cites this paper
• Temporal profiling of Kv1.3 channel expression in brain mononuclear phagocytes following ischemic stroke

  2019cites this paper
• MRI Evaluation of Axonal Remodeling After Combination Treatment With Xiaoshuan Enteric-Coated Capsule and Enriched Environment in Rats After Ischemic Stroke

  2019cites this paper
• Novel therapeutic strategies for stroke: The role of autophagy

  2019cites this paper
• Effect of oxidative stress in rostral ventrolateral medulla on sympathetic hyperactivity after traumatic brain injury

  2019cites this paper
• Neuroprotective Effects of AG490 in Neonatal Hypoxic-Ischemic Brain Injury

  2019cites this paper
• Neural Stem Cells Transfected with Reactive Oxygen Species–Responsive Polyplexes for Effective Treatment of Ischemic Stroke

  2019cites this paper
• Integration of phospholipid-complex nanocarrier assembly with endogenous N-oleoylethanolamine for efficient stroke therapy

  2019cites this paper